The Chemours Company (CC) Gabelli Funds' 16th Annual Specialty Chemicals Symposium summary

Conference overview

• Event focused on Chemours, a global chemical company with three main business segments: Titanium Technologies (TT), Thermal & Specialized Solutions (TSS), and Advanced Performance Materials (APM).

• Chemours has a market cap of $2.2 billion, net debt of $3.4 billion, and an enterprise value of $5.6 billion.

• 2023 sales totaled $6 billion with $800 million EBITDA; TSS had a 31% margin, TT and APM each at 12%.

• Leadership transition occurred in 2024, with new CFO and CEO aiming to execute a refreshed corporate strategy.

Business segment highlights

• TSS is transitioning from Freon to Opteon, a low global warming refrigerant, with double-digit growth expected in 2025.

• TT segment is in a cyclical trough, but $190 million in cost reductions over two years position it for margin improvement when demand recovers.

• APM focuses on performance solutions for semiconductors, EV batteries, and hydrogen, with delayed investments in green hydrogen due to market conditions.

• Portfolio optimization is a key strategy, including shutting down non-strategic European assets and optimizing product lines.

Financial and operational strategy

• Capital allocation prioritizes strategic growth, debt reduction, and liquidity, with a focus on secular growth industries like EVs and semiconductors.

• Fourth quarter 2023 saw $1.4 billion in sales and $179 million adjusted EBITDA, exceeding expectations.

• A $250 million cost-out program is underway, targeting $125 million in 2024 and run-rate savings into 2026.

• Sales CAGR above 5% is targeted over the next three years.